Physician

Daniel R Theesfeld

According to 2025 Medicare claims, Daniel Theesfeld (NPI: 1639120298) practices anesthesiology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is H8PAIN PAIN MANAGEMENT CENTER OF TEXAS PLLC (NPI: 1063743714) and primary practice location at 75605-5145.

Theesfeld's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 218 traditional Medicare patients, billed 4,884 HCPCS/CPT codes, and received $348,406 in Medicare payments. The top billing code was 95816 (Measurement of brain wave activity (eeg), awake and drowsy). Part D data shows 10,086 prescription claims across 481 beneficiaries totaling $376,159 in drug costs, led by Xtampza Er (Oxycodone Myristate). 2019 DME data shows 43 claims. Open Payments data shows 2 records totaling $29. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $781,720 to $376,159. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	415	6,552	$364,646
2016	359	5,660	$311,920
2017	343	5,929	$353,259
2018	319	5,370	$358,169
2019	319	5,977	$417,307
2020	282	5,505	$414,863
2021	258	5,706	$474,296
2022	202	4,700	$418,822
2023	267	5,537	$361,349
2024	218	4,884	$348,406

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	469	9,030	$781,720
2016	429	9,113	$943,698
2017	378	10,213	$1,125,459
2018	410	10,033	$1,137,304
2019	440	11,107	$1,057,017
2020	460	11,266	$515,173
2021	455	11,025	$533,037
2022	384	9,380	$399,124
2023	399	9,316	$398,128
2024	481	10,086	$376,159

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	122	348	$70,299
2016	45	89	$27,760
2017	53	55	$36,603
2018	40	40	$31,333
2019	43	43	$34,545
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95816	Measurement of brain wave activity (eeg), awake and drowsy	154	192	$262
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	199	1,161	$79
93923	Complete ultrasound study of arm and leg arteries	154	201	$79
92653	Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report	154	192	$56
93040	Electrocardiogram (ecg) 1 to 3 leads with review by physician	184	385	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtampza Er	Oxycodone Myristate	387	11,314	$136,545
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	2,507	72,861	$72,121
Oxycontin	Oxycodone Hcl	57	1,691	$33,215
Morphine Sulfate Er	Morphine Sulfate	1,456	42,545	$27,921
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	813	23,599	$22,236

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$29	Collegium Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel R. Theesfeld?

Tedicare shows public-source Medicare data for Daniel R. Theesfeld (NPI 1639120298), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel R. Theesfeld have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel R. Theesfeld?

Daniel R. Theesfeld is linked to H8PAIN PAIN MANAGEMENT CENTER OF TEXAS PLLC (billing NPI 1063743714) in the available physician profile data.

Does Daniel R. Theesfeld have Open Payments data?

Daniel R. Theesfeld has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.